Physician profile
Rajeev Sudhakar
NPI 1629215371
$3,975.13
in general payments reported to CMS, 2019-2025
22 companies · $704 in 2025
The $704 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $428 · 2022: $223 · 2023: $216 · 2024: $2,009 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,817 · Travel and Lodging: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,816.59 |
| Travel and Lodging | $1,112.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,477.26 | 2024 | Barostim Neo System |
| Abiomed | $543.88 | 2020-2022 | |
| Amgen INC. | $270.25 | 2024-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $264.61 | 2022-2023 | Watchman Flx, Watchman Access System |
| Inari Medical, INC. | $186.24 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $178.23 | 2019 | |
| Inspire Medical Systems, INC. | $158.59 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $149.34 | 2024-2025 | Farxiga |
| Heartflow, INC. | $143.55 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $131.93 | 2023-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.59 | 2019-2025 | Lifevest |
| Abbott Laboratories | $63.48 | 2024-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Sanofi-Aventis U.S. LLC | $58.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $46.53 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $45.07 | 2019-2025 | Eliquis |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $42.75 | 2019 | |
| Kestra Medical Technology Services, INC. | $37.34 | 2025 | Assure Wcd |
| Teleflex LLC | $23.02 | 2025 | Twin-Pass |
| Actelion Pharmaceuticals US, INC. | $20.92 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.41 | 2025 | Evkeeza |
| Itamar Medical INC | $17.97 | 2024 | Watchpatone |
| Scpharmaceuticals INC. | $16.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Sudhakar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.